Mode
Text Size
Log in / Sign up

In hospitalized children with human rhinovirus infection, lower airway obstruction and specific comorbidities associate with progression to bronchitis or pneumonia.

In hospitalized children with human rhinovirus infection, lower airway obstruction and specific como…
Photo by National Cancer Institute / Unsplash
Key Takeaway
Consider lower airway obstruction and comorbidities as potential risk markers for disease progression in hospitalized children with human rhinovirus infection.

A retrospective cohort study analyzed data from 1,125 hospitalized children diagnosed with human rhinovirus infection at the First Affiliated Hospital of Ningbo University. The primary objective was to evaluate risk factors associated with the progression of the infection to bronchitis or pneumonia. The study population consisted of children admitted to the hospital setting, with outcomes assessed based on clinical progression during their stay.

Regarding progression to bronchitis, the analysis revealed a positive association with lower airway obstruction. Children presenting with dyspnea had an odds ratio (OR) of 4.35 (95% CI: 2.35–8.06), wheezing on auscultation had an OR of 2.98 (95% CI: 1.89–4.69), and cough had an OR of 2.61 (95% CI: 1.52–4.49). Approximately 29% of the 1,125 children in the cohort experienced progression to bronchitis.

Progression to pneumonia was linked to prior antibiotic use, viral co-infection, and coagulation abnormalities. The odds ratios were 2.09 (95% CI: 1.34–3.25) for prior antibiotic use, 1.97 (95% CI: 1.25–3.10) for viral co-infection, and 1.04 (95% CI: 1.00–1.08) for coagulation abnormalities. Overall, 59% of the children progressed to pneumonia. Elevated IgM levels were identified as a common risk factor for progression to either condition, though specific effect sizes and absolute numbers for this factor were not reported. Conversely, older age demonstrated a protective effect against progression, with an OR of 0.89 (95% CI: 0.83–0.96).

The study did not report specific adverse events, discontinuations, or tolerability data. Key limitations inherent to the retrospective design and the absence of reported effect sizes for certain variables such as IgM levels must be considered. While the practice relevance suggests improving early risk stratification and guiding targeted interventions, clinicians should interpret these associations cautiously. The evidence is observational, meaning causal relationships cannot be established, and the findings may not be generalizable beyond the specific hospital setting.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundHuman rhinovirus (HRV) is a leading cause of acute respiratory infections and hospitalization in children. However, risk factors for progression to bronchitis vs. pneumonia remain incompletely characterized.ObjectiveThis study aimed to identify and distinguish independent predictors for these outcomes using a machine learning approach.MethodsA retrospective cohort study was conducted among hospitalized children with HRV infection at the First Affiliated Hospital of Ningbo University. A two-stage feature selection method (Random Forest and LASSO) was used, followed by multinomial logistic regression to quantify associations with progression to bronchitis or pneumonia.ResultsOf 1,125 children, 29% progressed to bronchitis and 59% to pneumonia. Multinomial logistic regression revealed distinct risk profiles. Progression to bronchitis was strongly associated with lower airway obstruction, including dyspnea (OR: 4.35, 95% CI: 2.35–8.06), wheezing on auscultation (OR: 2.98, 95% CI: 1.89–4.69), and cough (OR: 2.61, 95% CI: 1.52–4.49). Progression to pneumonia was uniquely linked to prior antibiotic use (OR: 2.09, 95% CI: 1.34–3.25), viral co-infection (OR: 1.97, 95% CI: 1.25–3.10), and coagulation abnormalities (OR: 1.04, 95% CI: 1.00–1.08). Elevated IgM was a common risk factor for both, while older age was protective against both (OR: 0.89, 95% CI: 0.83–0.96).ConclusionBronchitis progression is primarily associated with airway obstruction, whereas pneumonia is linked to more complex clinical scenarios, including prior medication, co-infections, and coagulopathy. These findings can improve early risk stratification and guide targeted interventions.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.